Lenz Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.11

+0.03 (+0.74%)

As of Sep 22, 2:56 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +240.1% upside

Low Target $9.74

Average Target $13.98

High Target $16.17

Current Price $4.11

Current
$4.11

Target
$13.98

$9.74 $13.98 avg $16.17

Scenario Analysis

Bear Case

$9.74

137.0%

Low target

Base Case

$13.98

+240.1%

Avg target

Bull Case

$16.17

+293.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$50.40

-91.8% from high

52-Week Low

$4.01

+2.5% from low

Target vs 52W High

$13.98

-72.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%